The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: Implications for TRH-based therapeutics

Journal of Pharmacology and Experimental Therapeutics

Volumn 305, Issue 2, 2003, Pages 410-416

  Gary, Keith A ^a   Sevarino, Kevin A ^a   Yarbrough, George G ^b   Prange Jr , Arthur J ^c   Winokur, Andrew ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b UNIVERSITY OF PORTLAND   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

[5 [(5 OXO 1 PHENYLMETHYL) 2 PYRROLIDINYL]METHYL] 5 [(1H IMIDAZOL 5 YL)METHYL]CYCLOHEXANEACETAMIDE; AZETIRELIN; JTP 2942; MONTIRELIN; POSATIRELIN; PROTIRELIN; PROTIRELIN DERIVATIVE; PROTIRELIN[3 (3,3 DIMETHYLPROLINAMIDE)]; PYRO 2 AMINOADIPYLHISTIDYLTHIAZOLIDINE 4 CARBOXAMIDE; RO 24 9975; SODIUM(2 METHYL 4 OXOCYCLOPENTYLCARBONYL)HISTIDYLPROLINAMIDE; TALTIRELIN; UNCLASSIFIED DRUG; YM 14637;

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN STEM; CENTRAL NERVOUS SYSTEM FUNCTION; CHRONOBIOLOGY; CLINICAL TRIAL; DEPRESSION; DRUG INDICATION; DRUG MECHANISM; HOMEOSTASIS; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LIMBIC SYSTEM; MESENCEPHALON; MONOTHERAPY; NEUROBIOLOGY; NEUROENDOCRINE SYSTEM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE; SPINAL CORD; SPINOCEREBELLAR DEGENERATION; TREATMENT INDICATION;

ANIMALS; CENTRAL NERVOUS SYSTEM; CHRONOBIOLOGY; HOMEOSTASIS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NEUROSECRETORY SYSTEMS; THYROTROPIN-RELEASING HORMONE;

EID: 0037405712     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.044040     Document Type: Review

References (40)

1. Bidaud I, Lory P, Nicolas M, Bulant M, and Ladram A (2002) Characterization and functional expression of cDNAs encoding thyrotropin-releasing hormone receptor from Xenopus laevis: identification of a novel subtype of thyrotropin-releasing hormone receptor. Eur J Biochem 269:4566-4576.
2. Dettmar PW and Metcalf G (1981) Is thyrotropin releasing hormone an endogenous ergotropic substance in the brain? Neuropharmacology 20:497-503.
3. Duval F, Macher J-P, and Mokrani M-C (1990) Difference between evening and morning thyrotropin responses to protirelin in major depressive episode. Arch Gen Psychiatry 47:443-448.
4. Engel W (1989) High-dose TRH treatment of neuromuscular diseases: summary of mechanisms and critique of clinical studies, in Thyrotropin Releasing Hormone: Biomedical Significance (Metcalf G and Jackson I eds) pp 462-472, New York Academy of Sciences, New York.
5. Faden A, Vinik R, and McIntosh T (1989) Thyrotropin-releasing hormone and central nervous system trauma, in Thyrotropin Releasing Hormone: Biomedical Significance (Metcalf G and Jackson I eds) pp 380-384, New York Academy of Sciences, New York.
6. Gary KA, Sollars PJ, Lexow N, Winokur A, and Pickard GE (1996) Thyrotropinreleasing hormone phase shifts circadian rhythms in hamsters. Neuroreport 7:1631-1634.
7. Gershengorn M and Osman R (2001) Insights into G protein-coupled receptor function using molecular models. Endocrinology 142:2-10.
8. Griffiths E (1986) Thyrotropin-releasing hormone: new applications in the clinic. Nature (Lond) 322:212-213.
9. Grünenthal (1997) Montirelin - A CNS Active TRH Analogue, pp 1-34, Grünenthal GmbH, Aachen, Germany.
10. Heuer H, Schafer M-H, O'Donnell D, Walker P, and Bauer K (2000) Expression of thyrotropin releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats. J Comp Neurol 428:319-336.
11. Horita A (1998) An update on the CNS actions of TRH and its analogs. Life Sci 62:1443-1448.
12. Horita A, Carino M, and Lai H (1986) Pharmacology of thyrotropin-releasing hormone. Ann Rev Toxicol 26:311-332.
13. Itil TM, Patterson CD, Polvan N, Mehta D, and Bergey B (1975) Clinical and CNS effects of oral and i.v. thyrotropin releasing hormone (TRH). Psychopharmacol Bull 11:29-30.
14. Kalivas P, Stanley D, and Prange A Jr (1987) Interaction between thyrotropinreleasing hormone and the mesolimbic dopamine system. Neuropharmacology 26:33-38.
15. Kinoshita K, Yamamura M, Sugihara J, Suzuki M, and Matsuoka Y (1998) Taltirelin hydrate (TA-0910): an orally active thyrotropin-releasing hormone mimetic agent with multiple actions. CNS Rev 4:25-41.
16. Kubek MJ and Garg BP (2002) Thyrotropin-releasing hormone in the treatment of intractable epilepsy. Pediatr Neurol 26:9-17.
17. Lexow N (1996) Localization and Expression of Thyrotropin Releasing Hormone in Rat and Cat Retina. Ph.D. Thesis, p 127, University of Pennsylvania, Philadelphia, PA.
18. Loosen PT and Prange A Jr (1982) Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. Am J Psychiatry 139:405-416.
19. Manaker S, Winokur A, Rostene WH, and Rainbow TC (1985) Autoradiographic localization of thyrotropin-releasing hormone receptors in the rat central nervous system. J Neurosci 5:167-174.
20. Marangell LB, George MS, Callahan AM, Ketter TA, Pazzaglia PJ, L'Herrou TA, Leverich GS, and Post RM (1997) Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients. Arch Gen Psychiatry 54:214-222.
21. Mason G, Garbutt J, and Prange AJ (1995) Thyrotropin-releasing hormone: focus on basic neurobiology, in Psychopharmacology - Fourth Generation of Progress (Bloom F and Kupfer D eds) pp 493-503, Raven Press, New York.
22. Mellow AM, Sunderland T, Cohen RM, Lawlor BA, Hill JL, Newhouse PA, Cohen MR, and Murphy DL (1989) Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease. Psychopharmacology 98:403-407.
23. Merchenthaler I, Csernus V, Csontos C, Petrusz P, and Mess B (1988) New data on the immunocytochemical localization of thyrotropin-releasing hormone in the rat central nervous system. Am J Anat 181:359-376.
24. Molchan SE, Mellow AM, Lawlor BA, Weingartner HJ, Cohen RM, Cohen MR, and Sunderland T (1990) TRH attenuates scopolamine-induced memory impairment in humans. Psychopharmacology 100:84-89.
25. Nillni EA and Sevarino KA (1999) The biology of pro-thyrotropin-releasing hormonederived peptides. Endocrine Rev 20:599-648.
26. Nishimura Y (1975) The cerebellum of rolling mouse Nagoya. Adv Neurol Sci 19:670-672.
27. Plotnikoff NP, Prange AJ Jr, Breese GR, Anderson MS, and Wilson IC (1972) Thyrotropin releasing hormone: enhancement of DOPA activity by a hypothalamic hormone. Science (Wash DC) 178:417-418.
28. Post RM and Weiss SR (1996) A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures. Mol Neurobiol 13:33-60.
29. Sattin A (1999) The role of TRH and related peptides in the mechanism of action of ECT. J ECT 15:76-92.
30. Scanlon M and Toft A (2000) Regulation of thyrotropin secretion, in Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text (Braverman L and Utiger R eds) pp 234-254, Lippincott, Williams and Wilkins, New York.
31. Sobue I, Matsuoka Y, Katoh K, and Sakuma A (1986) TRH therapy of ataxia in patients with SCD, in TRH and Spinocerebellar Degeneration (Sobue I ed) pp 173-188, Elsevier, Amsterdam.
32. Sobue I, Takayanagi T, Nakanishi T, Tsubaki T, Uono M, Kinoshita M, Igata A, Miyazaki M, Yoshida M, Ando K, and Hirose K (1983) Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations. J Neurol Sci 61:235-248.
33. Szuba M, Fernando A, Winokur A, and Gary K (1996). Nocturnal TRH administration acutely ameliorates bipolar depression, in Conference Proceeding of the American College of Neuropsychopharmacology, p 235, San Juan, Peurto Rico.
34. Tanabe (2002) Annual Report 2002: Tanabe Seiyaku Company, Ltd., Tokyo, Japan.
35. Vogel R, Frye G, Wilson J, Kuhn C, Mailman R, and Breese G (1980) Attenuation of the effect of punishment by thyrotropin releasing hormone: comparisons with chlordiazepoxide. J Pharmacol Exp Ther 212:153-161.
36. Winokur A (1991) The relevance of thyrotropin-releasing hormone to psychiatric disorders, in Neuropeptides in Psychiatry (Nemeroff CB ed) pp 15-28, American Psychiatric Association Press, Washington, DC.
37. Winokur A, Manaker S, and Kreider M (1989) TRH and TRH receptors in the spinal cord, in Thyrotropin Releasing Hormone: Biomedical Significance (Metcalf G and Jackson I eds) pp 314-324, New York Academy of Sciences, New York.
38. Winokur A, Manaker S, Pack AI, and Fishman AP (1988) Alterations in receptors for thyrotropin-releasing hormone, serotonin and acetylcholine in amyotrophic lateral sclerosis. Gen Comp Endocrinol 72:115-122.
39. Winokur A and Utiger R (1974) Thyrotropin-releasing hormone: regional distribution in rat brain. Science (Wash DC) 185:265-267.
40. Yarbrough GG (1983) Thyrotropin releasing hormone and CNS cholinergic neurons. Life Sci 33:111-118.